Thai Special Committee's Inspection of Chinese Vape Factories Raises Questions

Regulations by 2FIRSTS.ai
Apr.18.2024
Thai Special Committee's Inspection of Chinese Vape Factories Raises Questions
Thai Parliament approves budget for committee to visit China e-cigarette factories, sparking concerns over potential conflicts of interest.

According to newsdirectory3 on April 18th, the Thai House of Representatives has approved a budget to support a special committee to visit e-cigarette production factories in China. The Tobacco Control Network has expressed skepticism about the approval of the budget for this committee.

 

On April 17, 2024, Wanchat Suphachatra, Director of the Smoke-Free Social Health Expert Network in Thailand and former President of the World Medical Association, revealed that the committee is considering studying laws and measures to control and regulate e-cigarettes in Thailand, with plans to visit manufacturing factories and the e-cigarette market in China. This action has raised questions about the committee's fulfillment of its duties, as e-cigarettes are illegal products in Thailand.

 

The committee should play a role in diligently supervising and enforcing laws. Instead, it goes on factory visits as if to promote sales and production in Thailand. This will damage the image of the committee and parliament in Thailand.

 

Naowarat Charoenkha, director of the Thailand Health Promotion Institute, said that the committee must address the question of what benefits visiting e-cigarette production and distribution research would bring. This is because such visits are similar to the practices of international tobacco companies, which often lead to politicians, government officials, and media going abroad to visit factories to promote the sales of these products.

 

The Tobacco Control Network has taken note of the committee's work, which has already been mentioned. There are also individuals involved in the committee who have ties to international tobacco companies, which violates Article 5.3 of the World Health Organization Framework Convention on Tobacco Control, which prohibits individuals with shared interests with tobacco companies from participating in developing policies to control tobacco products. Therefore, visiting e-cigarette factories in China reflects the irregularity of the committee's operations, which is highly inappropriate and goes against the principles of tobacco control set by the World Health Organization.

 

Wit Kasemsap, Director of the Tobacco Control Research and Knowledge Management Center (CRC) at Ramathibodi University's Medical School in Thailand, has stated that the committee should research the enforcement procedures of various countries regarding e-cigarettes. If the committee wishes to learn more information, they should consult with the Ministry of Health or the Department of Digital Affairs, and could even invite representatives from the World Health Organization to provide information.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.